Product Code: TMRGL62667
Mobile Cardiac Telemetry Device Market - Scope of Report:
TMR's report on the global mobile cardiac telemetry device market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global mobile cardiac telemetry device market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global mobile cardiac telemetry device market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the mobile cardiac telemetry device market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global mobile cardiac telemetry device market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global mobile cardiac telemetry device market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global mobile cardiac telemetry device market.
The report delves into the competitive landscape of the global mobile cardiac telemetry device market. Key players operating in the global mobile cardiac telemetry device market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global mobile cardiac telemetry device market profiled in this report.
Key Questions Answered in Global Mobile Cardiac Telemetry Device Market Report:
- What is the sales/revenue generated by mobile cardiac telemetry device across all regions during the forecast period?
- What are the opportunities in the global mobile cardiac telemetry device market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Mobile Cardiac Telemetry Device Market - Research Objectives and Research Approach:
The comprehensive report on the global mobile cardiac telemetry device market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global mobile cardiac telemetry device market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global mobile cardiac telemetry device market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Mobile Cardiac Telemetry Device Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Disease Indication Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, 2017-2031
5. Key Insights
- 5.1. Technological Advancement
- 5.2. Regulatory Analysis
- 5.3. Disease Incidence and Prevalence
- 5.4. COVID-19 Impact Analysis
6. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Application
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Application, 2017 - 2031
- 6.3.1. Lead-based
- 6.3.2. Patch-based
- 6.4. Market Attractiveness Analysis, by Application
7. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Disease Indication
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Disease Indication, 2017-2031
- 7.3.1. Angina Pectoris
- 7.3.2. Atherosclerosis
- 7.3.3. Heart Failure
- 7.3.4. Others
- 7.4. Market Attractiveness, by Disease Indication
8. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Hospitals
- 8.3.2. Specialty Clinics
- 8.3.3. Diagnostic Centers
- 8.3.4. Home Care Settings
- 8.3.5. Others
- 8.4. Market Attractiveness Analysis, by End-user
9. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Mobile Cardiac Telemetry Device Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Application, 2017-2031
- 10.2.1. Lead-based
- 10.2.2. Patch-based
- 10.3. Market Value Forecast, by Disease Indication, 2017-2031
- 10.3.1. Angina Pectoris
- 10.3.2. Atherosclerosis
- 10.3.3. Heart Failure
- 10.3.4. Others
- 10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Hospitals
- 10.4.2. Specialty Clinics
- 10.4.3. Diagnostic Centers
- 10.4.4. Home Care Settings
- 10.4.5. Others
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Application
- 10.6.2. By Disease Indication
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe Mobile Cardiac Telemetry Device Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Application, 2017-2031
- 11.2.1. Lead-based
- 11.2.2. Patch-based
- 11.3. Market Value Forecast, by Disease Indication, 2017-2031
- 11.3.1. Angina Pectoris
- 11.3.2. Atherosclerosis
- 11.3.3. Heart Failure
- 11.3.4. Others
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Hospitals
- 11.4.2. Specialty Clinics
- 11.4.3. Diagnostic Centers
- 11.4.4. Home Care Settings
- 11.4.5. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Application
- 11.6.2. By Disease Indication
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific Mobile Cardiac Telemetry Device Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Application, 2017-2031
- 12.2.1. Lead-based
- 12.2.2. Patch-based
- 12.3. Market Value Forecast, by Disease Indication, 2017-2031
- 12.3.1. Angina Pectoris
- 12.3.2. Atherosclerosis
- 12.3.3. Heart Failure
- 12.3.4. Others
- 12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Hospitals
- 12.4.2. Specialty Clinics
- 12.4.3. Diagnostic Centers
- 12.4.4. Home Care Settings
- 12.4.5. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Application
- 12.6.2. By Disease Indication
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Mobile Cardiac Telemetry Device Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Application, 2017-2031
- 13.2.1. Lead-based
- 13.2.2. Patch-based
- 13.3. Market Value Forecast, by Disease Indication, 2017-2031
- 13.3.1. Angina Pectoris
- 13.3.2. Atherosclerosis
- 13.3.3. Heart Failure
- 13.3.4. Others
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Hospitals
- 13.4.2. Specialty Clinics
- 13.4.3. Diagnostic Centers
- 13.4.4. Home Care Settings
- 13.4.5. Others
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Application
- 13.6.2. By Disease Indication
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Mobile Cardiac Telemetry Device Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Application, 2017-2031
- 14.2.1. Lead-based
- 14.2.2. Patch-based
- 14.3. Market Value Forecast, by Disease Indication, 2017-2031
- 14.3.1. Angina Pectoris
- 14.3.2. Atherosclerosis
- 14.3.3. Heart Failure
- 14.3.4. Others
- 14.4. Market Value Forecast, by End-user, 2017-2031
- 14.4.1. Hospitals
- 14.4.2. Specialty Clinics
- 14.4.3. Diagnostic Centers
- 14.4.4. Home Care Settings
- 14.4.5. Others
- 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. Brazil
- 14.5.2. Mexico
- 14.5.3. Rest of Latin America
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Application
- 14.6.2. By Disease Indication
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2022
- 15.3. Company Profiles
- 15.3.1. BioTelemetry, Inc.
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Test Application Portfolio
- 15.3.1.3. Financial Overview
- 15.3.1.4. SWOT Analysis
- 15.3.1.5. Strategic Overview
- 15.3.2. ScottCare
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Test Application Portfolio
- 15.3.2.3. Financial Overview
- 15.3.2.4. SWOT Analysis
- 15.3.2.5. Strategic Overview
- 15.3.3. Biotricity Inc.
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Test Application Portfolio
- 15.3.3.3. Financial Overview
- 15.3.3.4. SWOT Analysis
- 15.3.3.5. Strategic Overview
- 15.3.4. Welch Allyn
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Test Application Portfolio
- 15.3.4.3. Financial Overview
- 15.3.4.4. SWOT Analysis
- 15.3.4.5. Strategic Overview
- 15.3.5. Applied Cardiac Systems, Inc.
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Test Application Portfolio
- 15.3.5.3. Financial Overview
- 15.3.5.4. SWOT Analysis
- 15.3.5.5. Strategic Overview
- 15.3.6. Medicomp, Inc.
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Test Application Portfolio
- 15.3.6.3. Financial Overview
- 15.3.6.4. SWOT Analysis
- 15.3.6.5. Strategic Overview
- 15.3.7. Preventice Solutions
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Test Application Portfolio
- 15.3.7.3. Financial Overview
- 15.3.7.4. SWOT Analysis
- 15.3.7.5. Strategic Overview
- 15.3.8. Telerhythmics LLC
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Test Application Portfolio
- 15.3.8.3. Financial Overview
- 15.3.8.4. SWOT Analysis
- 15.3.8.5. Strategic Overview
- 15.3.9. Zoll Medical Corporation
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Test Application Portfolio
- 15.3.9.3. Financial Overview
- 15.3.9.4. SWOT Analysis
- 15.3.9.5. Strategic Overview
- 15.3.10. iRhythm Technologies, Inc.
- 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.10.2. Test Application Portfolio
- 15.3.10.3. Financial Overview
- 15.3.10.4. SWOT Analysis
- 15.3.10.5. Strategic Overview